AbbVie
Public companyUSfounded 20132 fields
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechPartnered with Calico on aging drug research for over a decade before ending the alliance in 2025. | Partnered with Calico on aging drug research for over a decade before ending the alliance in 2025. | statnews.com |
| NanotechnologyBought Capstan's in vivo tLNP CAR-T program for $2.1 billion in cash. | Bought Capstan's in vivo tLNP CAR-T program for $2.1 billion in cash. | sec.gov |
Events
| Date | Event | ||
|---|---|---|---|
| Nov 12, 2025 | AbbVie ends its decade-long partnership with Calicostatnews.com· Deal· Longevity biotech | Longevity biotech | Deal |
About
- Source
- statnews.com (press, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | AbbVieCompany in Nanotechnology: Joined a field, Bought Capstan's in vivo tLNP CAR-T program for $2.1 billion in cash. | seed | sec.gov |
| Sep 25, 2026 | AbbVieCompany in Longevity biotech: Joined a field, Partnered with Calico on aging drug research for over a decade before ending the alliance in 2025. | seed | statnews.com |
| Sep 25, 2026 | AbbVieCompany: Added | seed | statnews.com |